Newborns at risk with SSRIs

Infants born to mothers who take SSRIs during late pregnancy face more than twice the risk of pulmonary hypertension compared with unexposed infants, research finds.

Scandinavian data on 1.6 million infants showed 0.3% of those exposed to an SSRI in late pregnancy developed persistent pulmonary hypertension, compared with 0.12% of those never exposed.

Newborns exposed to an SSRI only in early pregnancy had a less marked, but still significant, increased risk, with 0.19% experiencing persistent pulmonary hypertension, the study found.